Joan Fallon is the founder of Curemark. Curemark has raised $200M in total funding. Backed by hedge funds, family offices, high net worth individuals.
Joan Fallon is the Founder and CEO of Curemark, a biopharmaceutical company focused on developing novel therapies for serious diseases such as Autism, ADHD, Parkinson's Disease, and addiction. She has raised nearly $200 million for Curemark, primarily from alternative funding sources.
Full founder directory · Investor directory · Company funding database · Fundraising library